Guardant Health Claimed Company
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext®, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal® for early-stage cancer patients. The Guardant Health screening portfolio includes the FDA-approved Shield™ blood test colorectal cancer screening. read more
HR or Marketing? Claim Your Free Employer Account
Guardant Health VP of Investor Relations Salary
The average Guardant Health VP of Investor Relations earns an estimated $126,463 annually. Guardant Health's VP of Investor Relations compensation is $4,945 less than the US average for a VP of Investor Relations.
Last updated a month ago.
$77k
$120k
$129k
$225k
$126,463
Average Compensation
- $126,463
- avg. base
VP of Investor Relations Salaries at Guardant Health
Compensation at Guardant Health by Department
How VPs of Investor Relations at Guardant Health Rate Their Compensation
The majority of VPs of Investor Relations at Guardant Health believe they're not compensated fairly. 100% of VPs of Investor Relations at Guardant Health say they receive annual bonuses, and the majority (69%) are satisfied with their benefits. See more compensation ratings at Guardant Health
VP of Investor Relations Salaries at Similar Size Companies
×